FRANKFURT, April 29 — BioNTech said today that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm’s CEO Ugur Sahin told Der Spiegel weekly that it was “in the final stretches” of preparing its...
A medical worker prepares a dose of the ‘Comirnaty’ Pfizer-BioNTech Covid-19 vaccine inside the exhibition palace transformed into a vaccination centre in Nice as part of the coronavirus disease vaccination campaign in France, April 29, 2021. — Reuters picFRANKFURT, April 29 — BioNTech said today that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.
Separately, German Health Minister Jens Spahn also voiced confidence that teens would be able to get their jabs in coming months. BioNTech/Pfizer already applied for emergency US authorisation of their jab for 12 to 15-year-olds earlier this month.SpiegelThe move comes after BioNTech and Pfizer in late March announced that phase 3 clinical trials of their vaccine for children aged 12-15 showed it was 100 per cent effective in warding off the disease.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
US authorises Pfizer/BioNTech Covid vaccine for children 12 to 15 | Malay MailWASHINGTON, May 11 ― US regulators yesterday authorised Pfizer and BioNTech's Covid-19 vaccine for use in children as young as 12, widening the country's inoculation programme as vaccination rates have slowed significantly. The vaccine has been available under an emergency use authorisation (EUA)...
Read more »
Stars of TV drama Covid Oh Covid Nora Danish, Tiz Zaqyah infected with Covid-19Both actresses updated their fans on their condition through Instagram on Sunday (May 9).
Read more »
BioNTech 'confident' Covid shot works against Indian variantIts co-developed vaccine with Pfizer is already deployed in dozens of countries worldwide. FMTNews BioNTech Pfizer Covid19
Read more »